Quarterly ResultMay 14, 2026, 01:13 PM
BioHarvest Sciences Q1 Net Loss $2.64M; Revenue $8.51M; Going Concern
AI Summary
BioHarvest Sciences Inc. reported a net loss of $2.64 million for Q1 2026, an increase from $2.34 million in Q1 2025, despite a rise in revenues to $8.51 million from $7.86 million year-over-year. The company continues to face operating losses and has not achieved sustained cash-flow profitability, leading to a "going concern" warning. Operations in Israel are ongoing amidst regional hostilities, though no material adverse impact has been reported.
Key Highlights
- Net loss increased to $2.64 million in Q1 2026 from $2.34 million in Q1 2025.
- Revenues grew to $8.51 million in Q1 2026, up from $7.86 million in Q1 2025.
- Operating loss widened to $1.83 million in Q1 2026 from $1.72 million in Q1 2025.
- Cash and cash equivalents decreased to $19.17 million as of March 31, 2026, from $23.03 million at year-end 2025.
- Total shareholders' equity declined to $23.02 million from $25.45 million over the same period.
- Company issued a going concern warning due to historical operating losses and need for future financing.
- Operations in Israel continue despite intensified regional hostilities, with a temporary ceasefire in place.
- Granted 603,219 stock options and 262,830 Restricted Stock Units (RSUs) in March 2026.